Medical Devices North America

North America Tumor Ablation Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

North America Tumor Ablation Market Industry Trends and Forecast to 2034: Segmented by (Technology, Cancer, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

North America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $906.7 Mn Placeholder estimate
Estimate 2025 $996.4 Mn 50.5% of the global market
Projected 2034 $2.33 Bn 133.9% Adds $1.33 Bn over 9 forecast years
CAGR 2025–2034 9.9% Faster than 67% of 186 Medical Devices markets here
Key players 5
  • North America is 50.55% of the global market.
  • Among regions, the largest is North America (this report) at $996.4 Mn.
  • Fastest growing: APAC at 12.5% a year.
  • North America ranks 1st of 6 by size among regions.

Market size projection

North America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.33 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Tumor Ablation Market market size by year, North America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $906.7 Mn — —
2025 (base) $996.4 Mn +$89.8 Mn —
2026 (forecast) $1.10 Bn +$98.6 Mn +9.9%
2027 (forecast) $1.20 Bn +$108.4 Mn +20.8%
2028 (forecast) $1.32 Bn +$119.1 Mn +32.7%
2029 (forecast) $1.45 Bn +$130.9 Mn +45.9%
2030 (forecast) $1.60 Bn +$143.9 Mn +60.3%
2031 (forecast) $1.76 Bn +$158.2 Mn +76.2%
2032 (forecast) $1.93 Bn +$173.8 Mn +93.6%
2033 (forecast) $2.12 Bn +$191.0 Mn +112.8%
2034 (forecast) $2.33 Bn +$209.9 Mn +133.9%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

North America Tumor Ablation Market Analysis at a glance
Market size, 2025$996.4 Mn placeholder estimate
Forecast, 2034$2.33 Bn placeholder estimate
Growth (CAGR), 2025–20349.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTechnology, cancer and end user (see all)
Key playersMedtronic, Boston Scientific Corporation, Johnson & Johnson, AngioDynamics, Inc., HealthTronics (see all)
Active clinical trials100 in North AmericaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The North America Tumor Ablation Market Analysis Executive Summary

Tumour ablation destroys tumours with heat, cold or electric fields through a needle, instead of open surgery.

Key segments of the tumor Ablation market include technology (Radiofrequency Ablation, Microwave Ablation and Cryoablation) and cancer (Liver, Lung and Kidney).

Bar chart: North America Tumor Ablation market size, 2024–2034, placeholder estimates. $906.7 Mn in 2024, $996.4 Mn in 2025 and $2.33 Bn in 2034, 9.9% CAGR.
North America Tumor Ablation market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

North America Tumor Ablation Market Dynamics

Market Growth Drivers

Rising cancer cases, earlier detection, precision medicine and a strong pipeline of targeted and immune therapies are driving the tumor Ablation market. Faster approvals and new combinations are improving survival.

Opportunity

Biomarker-led treatment, earlier lines of therapy and expansion into emerging markets offer strong growth for the tumor Ablation market.

Market Restraints

High treatment costs, drug resistance, side effects and unequal access to cancer centres hold back the tumor Ablation market, especially in low- and middle-income countries.

Competitive Landscape for Tumor Ablation Market in North America

The tumor Ablation market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Tumor Ablation Market in North America

Tumor Ablation in North America: rules, payment and research

In the countries we cover here, medical devices are regulated by Health Canada (Canada)⁠[1] and FDA (US)⁠[2]. How care is paid for in these countries: provincial health insurance (Canada)⁠[3] and Medicare and Medicaid (US)⁠[4]. ClinicalTrials.gov lists 100 studies on Tumor Ablation that are recruiting, active or about to start in North America.⁠[5]

[1] Health Canada. Checked 14 Nov 2026.

[2] US Food and Drug Administration. Checked 14 Nov 2026.

[3] Health Canada. Checked 14 Nov 2026.

[4] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

[5] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how tumor Ablation products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in North America.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Tumor Ablation right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Tumor Ablation in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Tumor Ablation market in North America?
Placeholder estimate: about $996.4 Mn in 2025, rising to about $2.33 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Tumor Ablation market in North America growing?
Placeholder estimate: about 9.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Tumor Ablation market report cover?
The report splits the market by technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and more), cancer (Liver, Lung, Kidney, Bone) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Tumor Ablation market?
Key players include Medtronic, Boston Scientific Corporation, Johnson & Johnson, AngioDynamics, Inc. and HealthTronics.
What is driving the Tumor Ablation market?
Rising cancer cases, earlier detection, precision medicine and a strong pipeline of targeted and immune therapies are driving the tumor Ablation market. Faster approvals and new combinations are improving survival.
How many clinical trials on Tumor Ablation are running in North America?
100 studies are recruiting, active or about to start in North America, counted across the 2 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.
How much research is published on Tumor Ablation?
PubMed lists 1,479 papers on Tumor Ablation added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in North America

See all

Related on oncology

See the topic